Exploring the Potential of Sulfur Moieties in Compounds Inhibiting Steroidogenesis
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Exploring the Potential of Sulfur Moieties in Compounds Inhibiting Steroidogenesis. / Wróbel, Tomasz M.; Sharma, Katyayani; Mannella, Iole; Oliaro-Bosso, Simonetta; Nieckarz, Patrycja; Du Toit, Therina; Voegel, Clarissa Daniela; Rojas Velazquez, Maria Natalia; Yakubu, Jibira; Matveeva, Anna; Therkelsen, Søren; Jørgensen, Flemming Steen; Pandey, Amit V.; Pippione, Agnese C.; Lolli, Marco L.; Boschi, Donatella; Björkling, Fredrik.
I: Biomolecules, Bind 13, Nr. 9, 1349, 2023.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Exploring the Potential of Sulfur Moieties in Compounds Inhibiting Steroidogenesis
AU - Wróbel, Tomasz M.
AU - Sharma, Katyayani
AU - Mannella, Iole
AU - Oliaro-Bosso, Simonetta
AU - Nieckarz, Patrycja
AU - Du Toit, Therina
AU - Voegel, Clarissa Daniela
AU - Rojas Velazquez, Maria Natalia
AU - Yakubu, Jibira
AU - Matveeva, Anna
AU - Therkelsen, Søren
AU - Jørgensen, Flemming Steen
AU - Pandey, Amit V.
AU - Pippione, Agnese C.
AU - Lolli, Marco L.
AU - Boschi, Donatella
AU - Björkling, Fredrik
N1 - Publisher Copyright: © 2023 by the authors.
PY - 2023
Y1 - 2023
N2 - This study reports on the synthesis and evaluation of novel compounds replacing the nitrogen-containing heterocyclic ring on the chemical backbone structure of cytochrome P450 17α-hydroxylase/12,20-lyase (CYP17A1) inhibitors with a phenyl bearing a sulfur-based substituent. Initial screening revealed compounds with marked inhibition of CYP17A1 activity. The selectivity of compounds was thereafter determined against cytochrome P450 21-hydroxylase, cytochrome P450 3A4, and cytochrome P450 oxidoreductase. Additionally, the compounds showed weak inhibitory activity against aldo-keto reductase 1C3 (AKR1C3). The compounds’ impact on steroid hormone levels was also assessed, with some notable modulatory effects observed. This work paves the way for developing more potent dual inhibitors specifically targeting CYP17A1 and AKR1C3.
AB - This study reports on the synthesis and evaluation of novel compounds replacing the nitrogen-containing heterocyclic ring on the chemical backbone structure of cytochrome P450 17α-hydroxylase/12,20-lyase (CYP17A1) inhibitors with a phenyl bearing a sulfur-based substituent. Initial screening revealed compounds with marked inhibition of CYP17A1 activity. The selectivity of compounds was thereafter determined against cytochrome P450 21-hydroxylase, cytochrome P450 3A4, and cytochrome P450 oxidoreductase. Additionally, the compounds showed weak inhibitory activity against aldo-keto reductase 1C3 (AKR1C3). The compounds’ impact on steroid hormone levels was also assessed, with some notable modulatory effects observed. This work paves the way for developing more potent dual inhibitors specifically targeting CYP17A1 and AKR1C3.
KW - AKR1C3
KW - CYP17A1
KW - enzyme inhibition
KW - prostate cancer
U2 - 10.3390/biom13091349
DO - 10.3390/biom13091349
M3 - Journal article
C2 - 37759751
AN - SCOPUS:85172765608
VL - 13
JO - Biomolecules
JF - Biomolecules
SN - 2218-273X
IS - 9
M1 - 1349
ER -
ID: 370476533